SCIENTIFIC LITERATURE

Research literature review

Evidence-focused summaries and references to original scientific publications. Check study design, population, limitations and source material before drawing conclusions.

Research and safety notice: This library is for educational information, not medical advice. Research findings do not establish that a substance is safe or effective for human use. Product status and advertising restrictions vary by substance and jurisdiction. No purchase or treatment recommendation is made on this page.

Retatrutide

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a randomised phase 3 trial

PubMed · 2026-10-10

Journal: The Lancet. Publication date: 10 October 2026. PMID: 42810372. DOI: 10.1016/S0140-6736(26)01861-1. This publication reports a phase 3 randomised trial of retatrutide in adults with obesity and type 2 diabetes.

Limitations and interpretation

Interpret findings using the full paper, including its protocol, outcomes, adverse events and limitations. Do not treat a trial publication as a general treatment recommendation.

Open original source / literature record ↗